2025³â 08¿ù 11ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis

Global healthcare company will streamline operations and achieve end-to-end supply chain orchestration
´º½ºÀÏÀÚ: 2024-12-21

OTTAWA, ONTARIO -- Octapharma, the largest privately owned company dedicated to the research and development of life-saving or life-altering therapies, has selected Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, to connect data systems and modernize its supply chain.

Octapharma, headquartered in Lachen, Switzerland, focuses on three therapeutic areas: hematology, immunotherapy and critical care. Its products are available in 118 countries and reach hundreds of thousands of patients every year, having a direct impact on the quality of life of those patients and underscoring the importance of having a resilient and effective supply chain.

“Kinaxis is known within the life sciences and pharmaceutical community, and they understand the unique complexities that come along with managing our supply chains,” said Fabien Huyghe, strategic planning director at Octapharma. “We trust that their partnership will be hugely beneficial to our business.”

With the Kinaxis Maestro platform, Octapharma will orchestrate its supply chain, enabling the agility needed to make fast and accurate decisions, with positive impacts to the company’s bottom line.

“Being able to provide patients around the world with life-saving medicine is a huge honor and responsibility that we take seriously,” said Fabienne Cetre, executive vice president of EMEA at Kinaxis. “We are excited to partner with Octapharma on their supply chain journey to help them innovate and deliver more medicine to the people that need it the most.”

With the addition of Octapharma to its growing customer base, Kinaxis continues to cement its footprint within the life sciences industry, which provides the brand-name and generic medicines that countless patients rely on. Managing supply chain complexities in biotechnology, cell and gene therapy, medical devices, over-the-counter medicines and more, Kinaxis customers include some of the world‘s top pharma companies, such as Dr. Reddy’s, Jamieson Wellness, Merck, Novartis, Siemens Healthineers and Servier.



 Àüü´º½º¸ñ·ÏÀ¸·Î

SecurityBridge Acquires CyberSafe To Deliver Contextual SSO, MFA, And Passwordless Authentication To SAP Users
Kioxia Commences Sample Shipments of 9th Generation BiCS FLASHTM 512Gb TLC Devices
KnowBe4 Delivers AI-Driven Email Security to Small and Medium Businesses to Tackle Outbound Email Risk
Cisco Takes Licence to the Sisvel Wi-Fi 6 Patent Pool
HistoSonics¡¯ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation
Omdia: Cloud Platforms Drive $12.9bn Games Market Ecosystem
Latest Mouser Series Navigates the Balance of AI and Human Expertise in Engineering

 

DNP: Operational Launch of 2,500 mm-Width Coating Line to Enhance Prod...
ExaGrid Releases Version 7.3.0
MSCI Advances Private Markets Strategy With New Solutions Built for Ge...
Omdia: Asia¡¯s Game Subscription Market Set to Reach $9.4bn by 2029
Experian Assistant Wins 2025 Globee Award for Technology
Takeda Receives FDA 510(k) Clearance for HyHub¢â and HyHub¢â Duo Devic...
Ben Mauro¡¯s Sci-Fi Epic HUXLEY Launches Worldwide in Hardcover & Soft...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..